Efficacy of CapeOX plus Cetuximab Treatment as a First-Line Therapy for Patients with Extended RAS/BRAF/PIK3CA Wild-Type Advanced or Metastatic Colorectal Cancer
暂无分享,去创建一个
H. Nagano | J. Sakamoto | Y. Suehiro | S. Hazama | K. Oba | N. Okayama | N. Suzuki | H. Maeda | H. Mishima | S. Iwamoto | T. Yamasaki | N. Nagata